Crossmark

APOA1 and APOB polymorphisms and apolipoprotein concentrations as biomarkers of risk in acute coronary syndrome: Relationship with lipid-lowering therapy effectiveness

Crossref DOI link: https://doi.org/10.1016/j.medcle.2018.05.001

Published Print: 2018-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Casillas-Muñoz, Fidel

Valle, Yeminia

Muñoz-Valle, José Francisco

Martínez-Fernández, Diana Emilia

Reynoso-Villalpando, Gabriela Lizet

Flores-Salinas, Héctor Enrique

Llamas-Covarrubias, Mara Anaís

Padilla-Gutiérrez, Jorge Ramón
License Information

Text and Data Mining valid from 2018-07-01
More Information

This article is maintained by: Elsevier

Article Title: APOA1 and APOB polymorphisms and apolipoprotein concentrations as biomarkers of risk in acute coronary syndrome: Relationship with lipid-lowering therapy effectiveness

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2018.05.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2017.07.026

Content Type: article

Copyright: © 2017 Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below